- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07393230
Changes in Orbital Macrovascular and Intraocular Microvascular Blood Flow After Orbital Decompression Surgery in Patients With Thyroid Eye Disease (BOD-VASC)
Evaluation of the Effect of Bilateral Balanced Orbital Decompression on Orbital, Retinal, and Choroidal Macro and Microvascular Blood Flow Parameters in Thyroid-Associated Orbitopathy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Thyroid-associated orbitopathy (TAO) is an autoimmune condition that can lead to increased orbital tissue volume, proptosis, elevated intraocular pressure, and impaired venous outflow. In the inactive phase of the disease, balanced orbital decompression (BOD) is commonly performed to relieve orbital pressure and improve both anatomical and functional outcomes.
While the clinical benefits of orbital decompression are well established, its effects on orbital blood flow and intraocular microcirculation have not been sufficiently investigated, particularly over time. This study is designed to prospectively evaluate the impact of BOD on orbital macrovascular structures and retinal-choroidal microvascular networks in patients with inactive TAO.
Patients undergoing BOD for severe proptosis will be evaluated before surgery and at multiple postoperative follow-up visits. Assessments include clinical ophthalmologic examinations, intraocular pressure measurements, and imaging-based evaluation of orbital and intraocular circulation. Orbital macrovascular parameters will be assessed using Doppler ultrasonography, while retinal and choroidal microcirculation will be analyzed using optical coherence tomography angiography (OCTA).
The study aims to characterize time-dependent vascular changes following surgery and to explore the relationship between macrovascular and microvascular responses. By providing longitudinal data, this study seeks to improve understanding of how orbital decompression influences ocular perfusion and vascular regulation, contributing to a more comprehensive evaluation of surgical outcomes in inactive TAO.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pendik
-
Istanbul, Pendik, Turkey (Türkiye), 34899
- Marmara University School of Medicine, Department of Ophthalmology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 years or older
- Diagnosis of inactive thyroid-associated orbitopathy
- Presence of moderate-to-severe proptosis with indication for surgical orbital decompression
- Planned to undergo balanced orbital decompression surgery
- Ability to provide written informed consent
- Adequate image quality for OCTA and Doppler ultrasonography assessments
Exclusion Criteria:
- Active phase thyroid-associated orbitopathy
- Thyroid dysfunction or systemic condition contraindicating general anesthesia
- Proptosis due to causes other than TAO
- History of orbital radiotherapy
- Previous orbital or intraocular surgery
- Presence of retinal or choroidal pathology affecting vascular measurements
- History of systemic vasculitis or other vascular diseases
- Diabetes mellitus or systemic hypertension
- Use of systemic immunosuppressive therapy
- Age under 18 years
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Balanced Orbital Decompression Surgery
Participants in this arm undergo balanced orbital decompression surgery performed for inactive thyroid-associated orbitopathy, with preoperative and postoperative clinical and vascular assessments.
|
Balanced orbital decompression is performed under general anesthesia using a combined medial and lateral orbital wall approach with orbital fat removal, aiming to reduce orbital pressure and improve orbital and ocular circulation in patients with inactive thyroid-associated orbitopathy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in ophthalmic artery flow velocities
Time Frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Change in peak systolic velocity and end-diastolic velocity of the ophthalmic artery, measured in cm/s, assessed by color Doppler ultrasonography before and after surgery.
|
Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
|
Change in central retinal artery flow velocities
Time Frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Change in peak systolic velocity and end-diastolic velocity of the central retinal artery, measured in cm/s, assessed by color Doppler ultrasonography before and after surgery.
|
Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
|
Change in superior ophthalmic vein diameter
Time Frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Change in superior ophthalmic vein diameter, measured in millimeters (mm), assessed by magnetic resonance imaging before and after surgery.
|
Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in superficial capillary plexus vessel density
Time Frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Change in vessel density of the superficial capillary plexus, expressed as a percentage (%), assessed by optical coherence tomography angiography before and after surgery.
|
Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
|
Change in deep capillary plexus vessel density
Time Frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Change in vessel density of the deep capillary plexus, expressed as a percentage (%), assessed by optical coherence tomography angiography before and after surgery.
|
Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
|
Change in choriocapillaris vessel density
Time Frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Change in vessel density of the choriocapillaris, expressed as a percentage (%), assessed by optical coherence tomography angiography before and after surgery.
|
Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
|
Change in choroidal vascularity index
Time Frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Change in choroidal vascularity index (unitless), assessed by optical coherence tomography before and after surgery.
|
Baseline and postoperative follow-up visits at 1, 3, and 6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 09.2023.423 (Registry Identifier: Marmara University School of Medicine Ethics Committee)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Associated Orbitopathy
-
Osijek University HospitalCompletedThyroid Associated OrbitopathyCroatia
-
Lund UniversityRegion SkaneRecruitingGraves Ophthalmopathy | Thyroid Associated Ophthalmopathy | Thyroid Associated OrbitopathySweden
-
Sheba Medical CenterUnknown
-
Cairo UniversityCompletedThyroid Associated OrbitopathyEgypt
-
Sling Therapeutics, Inc.RecruitingEye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | HashimotoUnited States
-
Sling Therapeutics, Inc.Active, not recruitingEye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | HashimotoUnited States, Spain, Italy, United Kingdom, Canada
-
Lassen Therapeutics Inc.CompletedEye Diseases | Endocrine System Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | ProptosisUnited States, Spain, United Kingdom
-
Medical University of SilesiaRecruiting
-
University Hospital, MontpellierCompleted
-
Instituto de Oftalmología Fundación Conde de ValencianaCompletedThyroid Orbitopathy
Clinical Trials on Balanced Orbital Decompression Surgery
-
University of Sao Paulo General HospitalCompletedGraves OphthalmopathyBrazil
-
Hospital Universitario 12 de OctubreThe Queen Elizabeth Hospital; Hospital del Rio HortegaCompletedExophthalmos | Surgery | Orbitopathy, Graves
-
Sun Yat-sen UniversityNot yet recruitingThyroid Associated OphthalmopathyChina
-
Taipei Veterans General Hospital, TaiwanUnknown
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationUnknownBone Marrow | Avascular Necrosis of FemurTaiwan
-
Peking University People's HospitalUnknownLumbar Spinal Stenosis
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingThyroid Eye DiseaseChina
-
University of ValenciaCompletedTrigeminal Neuralgia | Microvascular Decompression | TeflonSpain
-
Seoul National University HospitalCompleted